European Pharmacopoeia Reference Standards A Lodi, Head of the Laboratory Department, EDQM, Council of Europe

Similar documents
Identification of the need and uses of a reference standard

11 th INTERNATIONAL SYMPOSIUM ON PHARMACEUTICAL REFERENCE STANDARDS. Siriphorn Laomanacharoen 21 December 2012

Pharmacopoeial Reference Standards

General concepts in the Ph. Eur.: theory and rationale

OMCL Network of the Council of Europe QUALITY ASSURANCE DOCUMENT

Primary / secondary standards in pharmaceutical QC. Dr. Christian Zeine LGC Standards GmbH. Webinar Series 2013 July 2013

SPECIFIC MONOGRAPHS. A Guide Through The Different Sections. Claude Coune

European Regulations for Medicines. Place and Role of the European Pharmacopoeia in Europe Ph. Eur. concept

Available online at ScienceDirect. Procedia Engineering 132 (2015 )

Impurity Control in the European Pharmacopoeia

Excipients Facing Increased Scrutiny How to Use Secondary Reference Standards to Help Maintain Regulatory Compliance

OMCL Network of the Council of Europe QUALITY ASSURANCE DOCUMENT

STANDARD OPERATING PROCEDURES. Handling and working with Analytical Standards

Documentation requirements for an initial consultation

A016 Traceability of measurement results compared to national and international measurement standards

The European Pharmacopoeia and the 3Rs

How the European Pharmacopoeia Provides the Framework to Implement QbD Principles

EDQM Overview of our products and services

Pharmaceutical Reference Standards: Overview and Role in Global Harmonization

FQS Accreditation for forensic testing agencies NEMC ANSI-ASQ National Accreditation Board

Consultation by a notified body on an ancillary medicinal substance integrated in a medical device

Certification of suitability to the Monographs of the European Pharmacopoeia

Examples of reference materials

Wirkstoffdokumentation & CEP- Verfahren

EDQM Overview of our products and services

Policy on the Traceability of Measurement Results

European Directorate for the Quality of Medicines & HealthCare (EDQM)

Ph. Eur. monographs and biosimilars

COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP) NOTE FOR GUIDANCE ON SUMMARY OF REQUIREMENTS FOR ACTIVE SUBSTANCES IN PART II OF THE DOSSIER

The European Approach on Large Sample Sizes in the context of a PAT Environment

European Medicines Agency Evaluation of Medicines for Human Use

Implementation of ICH Q3D in the Certification Procedure

GUIDANCE NOTE 37 MEDICAL GASES DATA INTEGRITY

Implementation of the ICH Q3D guideline in the Ph. Eur.

Public Assessment Report. Scientific discussion. Progesteron GLF 100 mg and 200 mg soft capsules. (progesterone) NL/H/3415/ /DC

OMCL Network of the Council of Europe QUALITY ASSURANCE DOCUMENT

How to build a good CEP application - ICH Q3D

Inspection of Quality Control Laboratories

English only/anglais seulement PA/PH/CEP (15) 31. Certification of suitability to the Monographs of the European Pharmacopoeia.

Guide. recombinant DNA proteins. for the elaboration of monographs on synthetic peptides and. European Pharmacopoeia

The procedure of Certification of Suitability to the Monographs of the European Pharmacopoeia (CEP) and the EDQM Inspection Programme

A61-01 CALA Traceability Policy Revision 3.2 September 16, 2016

Implementation of the ICH Q3D guideline in the Ph. Eur.

Technical Guide. vaccines and other immunological human medicinal products. for the elaboration of monographs on. European Pharmacopoeia

Proposals for the Guideline on Classification of Variations. Only those variations applicable to the active substance are listed.

Reference materials: Certificates

EDQM Conference. The European Pharmacopoeia Is it prepared for the future? Workshop 5. Workshop October 2010 Prague, Czech Republic

Procedure for Equipment Calibration and Maintenance

How to prepare an application for revision of a CEP

APPENDIX H TRACEABILITY OF MEASUREMENT

Journal of Chemical and Pharmaceutical Research

9/2/2014. USP Monograph Modernization. Todays topics. USP basic. Todays topics. - USP basic. - USP publications. - USP monograph modernization

Wilmington Police Department Crime Laboratory Quality Management System Procedure Measurement Traceability and Uncertainty

Thank You to United States Pharmacopeia for Their Sponsorship and Assistance

VALIDATION OF ANALYTICAL PROCEDURES: METHODOLOGY *)

Technical guide for the ELABORATION AND USE OF MONOGRAPHS ON HUMAN PLASMA- DERIVED PRODUCTS

EudraLex. Part I1 Chapter 6: Quality Control

Understanding CRM Second Source and Stability. Joe Konschnik RESTEK Corporation

ILAC-P10:01/2013 -Calibration-

á1225ñ VALIDATION OF COMPENDIAL PROCEDURES

SAPRAA Meeting Alternative API evaluation processes e.g. Confirmation of WHO API Prequalification - CPQ

(Information) INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES EUROPEAN COMMISSION

The European Pharmacopoeia

Certificate of Analysis

The Council of Europe. EDQM Milestones (1) EDQM Milestones (2) European Directorate for the Quality of

EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY. EudraLex. Volume 4

Content of the dossier for chemical purity and microbiological quality

Globalization of JP s Reference Standards

CONCEPT PAPER FOR COMMENT

National Air Quality Reference Laboratories and the European Network AQUILA:

Guideline on setting specifications for related impurities in antibiotics

LEGAL REQUIREMENTS FOR STABILITY

Annex 1. Good pharmacopoeial practices

Certificate of Analysis

PHARMACEUTICAL REFERENCE STANDARDS

Characterisation of non-compendial reference standards for impurities: How good is good enough?

Certificate of Analysis

ICH Q2(R1) A Primer. cgmp. GxP PIC/S SOP ISO QA/QC LOD/LOQ. Validation of Analytical Methods API EP FDA OECD GCP

Reference Standard Characterization. Steve Lane. General Manager, NSF Reference Standards.

Procedure for Biomedical Equipment Calibration and Maintenance

Validation of On-line Total Organic Carbon Analysers for Release Testing Using ICH Q2

Certificate of Analysis

PHARMACEUTICAL REFERENCE STANDARDS

Materials Management Traceability, CEPs and managing non-conforming sites

A GUIDELINE ON DOSSIER REQUIREMENTS FOR TYPE I VARIATIONS November 1999

NATA Policy on Calibration and Measurement Traceability

Verification of Compendial Methods

American Association for Laboratory Accreditation

GUIDELINES ON THE PRINCIPLES OF GOOD DISTRIBUTION PRACTICE OF ACTIVE SUBSTANCES FOR MEDICINAL PRODUCTS FOR HUMAN USE

NIRS, PAT, RTR testing EU experience and regulatory perspective

Salient Features of IP-2010 (VI edition)

ISO and SANAS guidelines for use of reference materials and PT scheme participation. T & M Conference

WELMEC European cooperation in legal metrology

A.1 Contents file 4 to 5 A.1 (1)

Elemental impurities Expectations for APIs and Excipients in the EU

Guidance for individual laboratories for transfer of quality control methods validated in collaborative trials with a view to implementing 3Rs

Annex 4. Model certificate of analysis

Advanced Concepts for Change Control of Analytical Procedures with ICH Q12 Coming

Certificate of Analysis

PHARMA KNOWLEDGE PARK

Transcription:

European Pharmacopoeia Reference Standards A Lodi, Head of the Laboratory Department, EDQM, Council of Europe Content Ph. Eur. Reference Standards General notices, terms and definitions Key attributes Establishment Distribution and storage Secondary Standards 1

Ph. Eur. General Notices Certain monographs require the use of reference standards. The European Pharmacopoeia Commission establishes the official reference standards, which are alone authoritative in case of arbitration. These reference standards are available from the European Directorate for the Quality of Medicines & HealthCare (EDQM). LIMITS Ph. Eur. General Notices The limits prescribed in a monograph are based on data obtained in normal analytical practice; they take account of normal analytical errors, of acceptable variations in manufacture and compounding and of deterioration to an extent considered acceptable. No further tolerances are to be applied to the limits prescribed to determine whether the article being examined complies with the requirement of the monograph. 2

EUROPEAN PHARMACOPOEIA LINK BETWEEN TEXTS AND REFERENCE STANDARDS Reference Standards Methods Specifications Ph.Eur. Chapter 5.12. Chapter for information Content: Terminology Use of Reference Standards Establishment of Reference Standards Processing, Labelling, Storage and Distribution Re-Test Programme 3

PH. EUR. REFERENCE STANDARDS Ph. Eur. Chapter 5.12. 4/2015 The term Reference standard is used as a general term covering reference substances, preparations and spectra. Reference standards are used to achieve adequate quality control of substances for pharmaceutical use and pharmaceutical preparations. PH. EUR. REFERENCE STANDARDS Ph. Eur. Chapter 5.12. 4/2015 Ph.Eur. RS: reference standard established under the aegis of and adopted by the European Pharmacopoeia Commission. Ph. Eur. chemical reference substance (CRS) & biological reference preparation (BRP): substance or mixture of substances intended for use as stated in a monograph or general chapter of the European Pharmacopoeia. Ph. Eur. herbal reference substance (HRS): herbal drug preparation or herbal drug intended for use as stated in a monograph or general chapter of the European Pharmacopoeia. 4

TERMS AND DEFINITIONS ISO GUIDE 30:2015 - Ph. Eur. Chapter 5.12. 4/2015 Reference Material Material, sufficiently homogeneous and stable with respect to one or more specified properties 1, which has been established to be fit for its intended use 2 in a measurement process. 1 Properties can be quantitative or qualitative 2 Uses may include calibration/assessment of a measurement system/procedure, assigning values to other materials and quality control ISO GUIDE 30:2015 - Ph. Eur. Chapter 5.12. 4/2015 Certified Reference Material (CRM) Reference material characterized by a metrologically valid procedure for one or more specified properties, accompanied by a certificate that provides the value of the specified property, its associated uncertainty, and a statement of metrological traceability. 5

TYPES OF PH. EUR. REFERENCE STANDARDS Impurities (qualitative 11% Mixtures for SST/peak ID. 16% Identification 45% Impurities quantitative 11% Assay 17% Ph. Eur. need CRS LIFECYCLE Procurement Processing Packaging QC SDS Adoption Release Distribution Characterization Establishment Information leaflet Validity statement USERS Help Desk Monitoring Replacement Batch needed 6

EXAMPLE: RS FOR IDENTIFICATION EXAMPLE: RS FOR PEAK ID / SST 7

EXAMPLE HRS (quantitative use) LC assay Valerian dry extract HRS with assigned content for valerenic acid: ASSAY CRS 8

Ph. Eur. assay reference standards why no uncertainty? ISO GUIDE 34 : 2009 5.17 ISO GUIDE 31 : 2015 5.3.2 In some cases that are covered by specific legislation (e.g. most pharmacopoeia assay standards) the uncertainties of the assigned values are not stated since they are considered to be negligible in relation to the defined limits of the method specific assays for which they are used. Reference Standard Leaflet 9

Monitoring (retest-programme) No expiry date is given: see batch validity statement After establishment and adoption there is a standardized testing procedure in order to assure the «fitness for use» of the reference standards. Depending on the use and the known or predicted stability, substances are retested every 12, 24, 36 or 60 months Items of retesting: All properties which might be subject to change in the life cycle of a CRS, e.g.: - Water content - Purity by LC, GC or TLC - Possibly IR, UV SECONDARY STANDARDS 10

Secondary Standards - Requirements Ph.Eur. 5.12 paragraph 4-5. (for information) A secondary standard should exhibit the same property or properties as the primary standard, relevant for the test(s) for which it is established. The extent of testing is not so great as is required for the establishment of a primary standard. The secondary standard is established by comparison with the primary standard to which it is traceable. An official primary standard is used wherever possible for establishment of secondary standards. It is the responsibility of the user to justify/document the suitability of secondary standards. EU GMP Annex VI - 6.20 Whenever compendial reference standards from an official source exist, these should preferably be used as primary reference standards unless fully justified the use of secondary standards is permitted once their traceability to primary standards has been demonstrated and is documented. 11

TRACEABILITY Metrological traceability property of a measurement result whereby the result can be related to a reference through a documented unbroken chain of calibrations, each contributing to the measurement uncertainty International vocabulary of metrology Basic and general concepts and associated terms (VIM) 3rd edition Commercial Secondary Standards Example: Paracetamol Ph.Eur. CRS (no assigned content value) Used in monograph 0049 Paracetamol for: Identification by IR Assay determination in the monograph: Titration 12

Secondary Standards??? Traceability take home messages Ph. Eur. CRS official, legally binding standards, an essential part of Ph. Eur. monographs; established and guaranteed for their intended use(s); EDQM provides RS information (leaflet) and assistance (Helpdesk); Ph. Eur. policy on reference standard is reflected in general chapter 5.12. Secondary standards metrological traceable to primary standards for the relevant property, their suitability for use has to be justified, documented and maintained. 13

Thank you for your attention! 14